MedPath

Early Prediction of Placenta Accreta by Ultrasound and Color Doppler

Completed
Conditions
Placenta Accreta
Registration Number
NCT03032770
Lead Sponsor
Assiut University
Brief Summary

Placenta accreta is a substantially life threatening condition and one of the causes of maternal morbidity and mortality in the world. According to study done in United Kingdom, The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta previa. in a tertiary south Italian center, The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of placenta accreta was 3.7 per 1000 deliveries.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
148
Inclusion Criteria
  1. Low implantation of the gestational sac (<4 cm from external os) by transvaginal ultrasound
  2. Presence of placental lakes by transvaginal ultrasound
  3. Disruption of placental-myometrial interface by transvaginal ultrasound
  4. Trophoblast overlapping a uterine scar (Cesarean section, myomectomy) by transvaginal ultrasound
  5. Intraplacental dilated vessels by Doppler ultrasound
  6. Turbulent blood flows by Doppler ultrasound
  7. Greatly increased periplacental vascularity by Doppler ultrasound
Exclusion Criteria

a) Cases far away from our hospital and expected to be lost to be followed. b) Pregnant women who will refuse to Participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Confirmation of occurrence of placenta accreta during delivery.duration of pregnancy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assiut University

🇪🇬

Assiut, Egypt

Assiut University
🇪🇬Assiut, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.